Violaine Planté-Bordeneuve

6PUBLICATIONS
48CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyAutonomic nervous systemPredictive and prognostic markersNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2026
Rituximab With or Without Chemotherapy for Anti-MAG Neuropathy: A Retrospective Multicenter Real-World Study.

|Jul 09, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026.

|Jan 28, 2024
Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy.

Violaine Planté-Bordeneuve, Valentine Perrain

|Mar 30, 2023
A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis.

Violaine Planté-Bordeneuve, Farida Gorram, Malin Olsson

|Jul 25, 2022
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.

David Adams, Ivailo L Tournev, Mark S Taylor

|Nov 04, 2020
New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden.

Farida Gorram, Malin Olsson, Flora Alarcon

Pageof 1

Frequent Collaborators

2 joint publications

Marcia Waddington-Cruz

2 joint publications

Laura Obici

2 joint publications

John L Berk

2 joint publications

Intissar Anan